These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6301461

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.
    Reck F, Ehmann DE, Dougherty TJ, Newman JV, Hopkins S, Stone G, Agrawal N, Ciaccio P, McNulty J, Barthlow H, O'Donnell J, Goteti K, Breen J, Comita-Prevoir J, Cornebise M, Cronin M, Eyermann CJ, Geng B, Carr GR, Pandarinathan L, Tang X, Cottone A, Zhao L, Bezdenejnih-Snyder N.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5392-409. PubMed ID: 25155913
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Increased expression of biodegradative threonine dehydratase of Escherichia coli by DNA gyrase inhibitors.
    Sumantran VN, Tranguch AJ, Datta P.
    FEMS Microbiol Lett; 1989 Nov 01; 53(1-2):37-40. PubMed ID: 2558950
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity.
    Higgins NP, Peebles CL, Sugino A, Cozzarelli NR.
    Proc Natl Acad Sci U S A; 1978 Apr 01; 75(4):1773-7. PubMed ID: 347446
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor.
    Nayar AS, Dougherty TJ, Reck F, Thresher J, Gao N, Shapiro AB, Ehmann DE.
    Antimicrob Agents Chemother; 2015 Jan 01; 59(1):331-7. PubMed ID: 25348539
    [Abstract] [Full Text] [Related]

  • 31. DNA unknotting activity (DNA topoisomerase II) isolated from a thermophilic archaebacterium Sulfolobus is inhibited by novobiocin. Partial purification, identification of the two subunits and characteristics of the enzyme.
    Assairi LM.
    Biochim Biophys Acta; 1994 Sep 13; 1219(1):107-14. PubMed ID: 8086447
    [Abstract] [Full Text] [Related]

  • 32. Chlorhexidine hypersensitivity of ciprofloxacin-resistant variants of Pseudomonas aeruginosa PAO.
    Baillie LW, Power EG, Phillips I.
    J Antimicrob Chemother; 1993 Feb 13; 31(2):219-25. PubMed ID: 8385092
    [Abstract] [Full Text] [Related]

  • 33. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC, Shahied SI.
    Arch Biochem Biophys; 1995 Dec 01; 324(1):123-9. PubMed ID: 7503546
    [Abstract] [Full Text] [Related]

  • 34. Effect of DNA gyrase inhibitors and urea on the expression of cysB, the regulatory gene of the cysteine regulon.
    Bielińska A, Hulanicka D.
    J Gen Microbiol; 1986 Sep 01; 132(9):2571-6. PubMed ID: 2432161
    [Abstract] [Full Text] [Related]

  • 35. Requirement of DNA gyrase for the initiation of chromosome replication in Escherichia coli K-12.
    Filutowicz M.
    Mol Gen Genet; 1980 Jan 01; 177(2):301-9. PubMed ID: 6245341
    [Abstract] [Full Text] [Related]

  • 36. Effect of novobiocin and other DNA gyrase inhibitors on virus replication and DNA synthesis in herpes simplex virus type 1-infected BHK cells.
    Francke B, Margolin J.
    J Gen Virol; 1981 Feb 01; 52(Pt 2):401-4. PubMed ID: 6270241
    [Abstract] [Full Text] [Related]

  • 37. Quinolones: pharmacology.
    Verbist L.
    Pharm Weekbl Sci; 1986 Feb 21; 8(1):22-5. PubMed ID: 3008075
    [Abstract] [Full Text] [Related]

  • 38. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P, Nagaraja V.
    Mol Microbiol; 2005 Dec 21; 58(5):1392-405. PubMed ID: 16313624
    [Abstract] [Full Text] [Related]

  • 39. Isolation and characterization of novobiocin-resistant BHK cells.
    Ishida R, Nishizawa M, Fukami K, Maekawa K, Takahashi T, Nishimoto T.
    Somat Cell Mol Genet; 1987 Jan 21; 13(1):11-20. PubMed ID: 2433772
    [Abstract] [Full Text] [Related]

  • 40. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
    Tabary X, Moreau N, Dureuil C, Le Goffic F.
    Antimicrob Agents Chemother; 1987 Dec 21; 31(12):1925-8. PubMed ID: 2830840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.